Trastuzumab resistance accompanies vasculogenic mimicry in HER2-positive breast cancer cells

被引:0
|
作者
Shimoda, Masafumi [1 ]
Noguchi, Shinzaburo [1 ]
机构
[1] Osaka Univ, Sch Med, Dept Breast Endocrine Surg, Suita, Osaka, Japan
来源
CANCER SCIENCE | 2018年 / 109卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
J-1031
引用
收藏
页码:311 / 311
页数:1
相关论文
共 50 条
  • [21] Mechanisms of resistance to trastuzumab in HER2-positive gastric cancer
    Li, Zhifei
    Zhao, Huan
    Hu, Huihui
    Shang, Haili
    Ren, Yongjing
    Qiu, Wenhui
    Su, Hao
    Lyu, Huifang
    Chen, Xiaobing
    CHINESE JOURNAL OF CANCER RESEARCH, 2024, 36 (03)
  • [22] Trastuzumab plus Paclitaxel in HER2-positive Breast Cancer
    不详
    GYNAKOLOGE, 2016, 49 (08): : 558 - 558
  • [23] Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
    Verma, Sunil
    Miles, David
    Gianni, Luca
    Krop, Ian E.
    Welslau, Manfred
    Baselga, Jose
    Pegram, Mark
    Oh, Do-Youn
    Dieras, Veronique
    Guardino, Ellie
    Fang, Liang
    Lu, Michael W.
    Olsen, Steven
    Blackwell, Kim
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (19): : 1783 - 1791
  • [24] Personalized drug combinations to overcome trastuzumab resistance in HER2-positive breast cancer
    Vu, Thuy
    Sliwkowski, Mark X.
    Claret, Francois X.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2014, 1846 (02): : 353 - 365
  • [25] Trastuzumab therapy in HER2-positive, metastatic breast cancer
    Smith, A. D.
    Guilbert, K.
    Lister, D.
    Streilein, S.
    Bourrier, V. C.
    Lozar, B.
    Navaratnam, S.
    Harding, G. A.
    Pitz, M. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [26] Subcutaneous Trastuzumab: A Review in HER2-Positive Breast Cancer
    Young-A Heo
    Yahiya Y. Syed
    Targeted Oncology, 2019, 14 : 749 - 758
  • [27] Trastuzumab Deruxtecan in HER2-positive metastatic Breast Cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2024, 84 (08) : 670 - 670
  • [28] The art of prescribing trastuzumab for HER2-positive breast cancer
    Outhoff, K.
    SOUTHERN AFRICAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2011, 3 (01) : 16 - 26
  • [29] Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer
    Harris, Lyndsay N.
    You, Fanglei
    Schnitt, Stuart J.
    Witkiewicz, Agnes
    Lu, Xin
    Sgroi, Dennis
    Ryan, Paula D.
    Come, Steven E.
    Burstein, Harold J.
    Lesnikoski, Beth-Ann
    Kamma, Madhavi
    Friedman, Paula N.
    Gelman, Rebecca
    Iglehart, J. Dirk
    Winer, Eric P.
    CLINICAL CANCER RESEARCH, 2007, 13 (04) : 1198 - 1207
  • [30] Mechanisms of Resistance to Trastuzumab and Novel Therapeutic Strategies in HER2-Positive Breast Cancer
    Wong, Andrea L. A.
    Lee, Soo-Chin
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2012, 2012